Characterization of binge-dosed methamphetamine-induced neurotoxicity and neuroinflammation

Sarah E A McConnell1, M Kerry O'Banion1, Deborah A Cory-Slechta2

  • 1Department of Neurobiology and Anatomy, University of Rochester School of Medicine and Dentistry, 601 Elmwood Ave, Box 603, Rochester, NY 14642, USA.

Neurotoxicology
|August 19, 2015
PubMed

Insights

Methamphetamine (MA) causes neurotoxicity and neuroinflammation in mice. This study clarifies how MA

Area of Science:

  • Neuroscience
  • Toxicology
  • Pharmacology

Background:

  • Methamphetamine (MA) is a highly addictive psychostimulant with known neurotoxic and neuroinflammatory effects.
  • The precise relationship between MA-induced neuroinflammation and neurotoxicity remains unclear.
  • Understanding this link is crucial for developing effective interventions against MA abuse.

Purpose of the Study:

  • To investigate the temporal and dose-dependent relationship between MA-induced neurotoxicity and neuroinflammation.
  • To elucidate the time course of glial activation and dopaminergic terminal damage following MA binge exposure.

Main Methods:

  • Adult male mice received binge MA treatment (2-8 mg/kg) with injections every 2 hours.
  • Mice were analyzed at 1, 3, 7, and 14 days post-treatment.
  • Neurotoxicity markers (dopamine levels, TH, DAT) and neuroinflammation markers (glial activation) were assessed.

Main Results:

  • MA binge treatment dose-dependently induced hyperthermia, hypoactivity, and striatal dopamine depletion.
  • Dopamine turnover peaked at 7 days, while tyrosine hydroxylase and dopamine transporter levels showed partial recovery by 14 days.
  • MA activated striatal glia (astrocytes and microglia) within 1 day, with astrocyte activation persisting longer than microglial activation.

Conclusions:

  • MA-induced neuroinflammation is closely linked to neurotoxicity, with specific temporal and dose-dependent dynamics.
  • Glial activation, particularly astrocyte activation, plays a significant role in the neurotoxic effects of MA.
  • These findings provide critical insights into the mechanisms underlying MA neurotoxicity and inform potential therapeutic strategies.

Related Concept Videos

Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.5K
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
1.3K
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
174
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.5K